|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01099 SINOPHARM
Nominal 
16.200 +0.300 (+1.887%) | 2020/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | 2017/12 RMB(K¥) | 2016/12 RMB(K¥) | ||
| Turnover | 203,764,712 | 1.041% | 425,272,726 | 344,525,821 | 308,353,579 | 258,387,689 | |
| Cost of Sales | (186,522,837) | 1.272% | (387,741,423) | (313,297,729) | (282,304,714) | (237,717,016) | |
| Gross Profit | 17,241,875 | -1.390% | 37,531,303 | 31,228,092 | 26,048,865 | 20,670,673 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (697,225) | 42.762% | (416,391) | (357,336) | -- | -- | |
| Profit / (Loss) on Disposal | (388,070) | -- | (1,950,177) | (1,328,832) | -- | -- | |
| Other Non-operating Items | 85,763 | -- | (120,544) | 81,828 | 379,251 | 410,732 | |
| Share of Results of Asso. & JCEs | 369,086 | -6.535% | 887,074 | 843,169 | 476,879 | 232,190 | |
| Profit / (Loss) before Taxation | 6,217,134 | -2.649% | 13,759,810 | 12,207,940 | 11,226,799 | 8,924,822 | |
| Taxation | (1,413,753) | -0.306% | (3,139,738) | (2,803,456) | (2,561,821) | (2,033,227) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (1,907,699) | -4.282% | (4,367,535) | (3,568,642) | (3,089,394) | (2,244,251) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,895,682 | -2.672% | 6,252,537 | 5,835,842 | 5,575,584 | 4,647,344 | |
| Net Finance Costs / (Income) | 1,427,665 | -4.133% | 3,137,424 | 2,766,396 | 2,769,719 | 1,931,820 | |
| Depreciation & Amortisation | 1,591,260 | 19.453% | 3,114,076 | 1,394,679 | 1,240,044 | 1,067,761 | |
| Directors' Emoluments | -- | -- | 25,762 | 20,543 | 23,315 | 17,845 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 93.000 | -- | 211.000 | 197.000 | 188.000 | 168.000 |
| DPS (cts) | 0.000 | -- | 60.000 | 59.000 | 57.000 | 50.000 |
| Dividend Payout Ratio (%) | -- | -- | 28.436% | 29.949% | 30.319% | 29.762% |
| Cash flow per share ($) | -- | -- | 6.323 | 1.231 | 1.082 | 3.354 |
| NBV per share ($) | 16.653 | -- | 15.958 | 14.410 | 13.842 | 11.496 |
| Remarks: | Real time quote last updated: 20/10/2020 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,895,682 |
| %Change | -2.672% |
| EPS / (LPS) | RMB 0.930 |
| NBV Per Share (¥) | RMB 16.653 |